Statins Current Events | Statins News | 3
|
| Page
3 of
8 |
144 Results |
|
|
|
Sort By:
Page Views | Date |
Statin treatment may curb Alzheimer's brain changes
People who take statin drugs may be less likely to develop the brain changes that signal Alzheimer's disease, according to a study published in the August 28, 2007, issue of Neurology(r), the medical journal of the American Academy of Neurology. view more (2007-08-28)
Statin therapy ineffective in breast cancer prevention
Laboratory work in animals showed limited activity when statins were given to prevent breast cancer, according to a report in the February issue of Cancer Prevention Research, a journal of the American Association for Cancer Research. view more (2009-02-05)
Cholesterol treatment, including statins, may slow Alzheimer's disease progression
Cholesterol lowering drugs, including statins, may slow the progression of Alzheimer's disease, concludes a study in the Journal of Neurology Neurosurgery and Psychiatry. view more (2005-11-17)
Call for removal of Crestor (p 2189)
The author of a letter in this week's issue of THE LANCET is calling for the removal of the statin rosuvastatin (Crestor) from the drug market, based on data suggesting that it has a poorer safety profile than other licensed statin drugs. A Lancet editorial (Lancet 2003; 362: 1341) voiced concerns about the high-profile marketing of rosuvastatin... view more... (2004-06-23)
A scientific breakthrough on the control of the bad cholesterol
A study performed by the team of Dr. Nabil G. Seidah, Director of the Biochemical Neuroendocrinology Research Unit at the IRCM, shows for the very first time that the degradation by PCSK9 of the LDLR receptor view more (2008-11-25)
Early statin therapy for patients with acute coronary syndromes reduces death, cardiovascular events
Early, intensive therapy with statin medications reduces death and cardiovascular events for patients who have had heart attacks or other acute heart events. view more (2006-09-26)
Statins don't lower risk of pneumonia in elderly
Taking popular cholesterol-lowering statin drugs, such as Lipitor® (atorvastatin), does not lower the risk of pneumonia. view more (2009-06-17)
'Statins' linked to improved survival in kidney transplant recipients
For patients receiving kidney transplants, treatment with cholesterol-lowering "statin" drugs may lead to longer survival, reports a study in the November 2008 Journal of the American Society of Nephrology (JASN). view more (2008-07-24)
No evidence that widely prescribed statins protect against prostate cancer
A large community-based study refutes previous findings that statins - a top-selling drug class, worldwide -- might cut one's risk of developing prostate cancer by reducing production of the male hormones that fuel cancer growth. view more (2007-08-10)
First comprehensive paper on statins' adverse effects released
A paper co-authored by Beatrice Golomb, MD, PhD, associate professor of medicine at the University of California, San Diego School of Medicine and director of UC San Diego's Statin Study group cites nearly 900 studies on the adverse effects of HMG-CoA reductase inhibitors (statins), a class of drugs widely used to treat high cholesterol. view more (2009-01-27)
Researchers find specific statin significantly reduces Alzheimer's and Parkinson's disease risk
Researchers from Boston University School of Medicine (BUSM) have found that the statin, simvastatin, reduces the incidence of Alzheimer's disease and Parkinson's disease by almost 50 percent. view more (2007-07-19)
6.5 million more patients might benefit from statins to prevent heart attacks, strokes
Millions more patients could benefit from taking statins, drugs typically used to prevent heart attacks and strokes, than current prescribing guidelines suggest, Johns Hopkins doctors report in a new study. view more (2009-03-19)
Low cholesterol associated with cancer in diabetics
Low levels of LDL cholesterol as well as high levels are associated with cancer in patients with type 2 diabetes. view more (2008-08-26)
Study shows risk of acute pancreatitis low with statins
New research reveals that while cholesterol-lowering drugs do increase the risk of painful inflammation of the pancreas, the side effect is relatively rare, according to Sonal Singh, M.D., from Wake Forest University School of Medicine, and colleagues. view more (2007-01-02)
Statins, beta-blockers lessen heart attack risk, says Stanford-Kaiser study
or patients with undiagnosed heart disease, taking medications known as statins and beta-blockers may mean the difference between suffering a heart attack as a first symptom versus experiencing mild chest pain. view more (2006-02-21)
New tool finds best heart disease and stroke treatments for patients with diabetes
Researchers from North Carolina State University and Mayo Clinic have developed a computer model that medical doctors can use to determine the best time to begin using statin therapy in diabetes patients to help prevent heart disease and stroke. view more (2009-06-30)
UK study suggests statins may reduce diabetes risk
For the first time a statin drug has been shown to reduce the risk of type 2 diabetes, according to a UK study published in the latest issue of Circulation: Journal of the American Heart Association. A research team led by Allan Gaw, director of the Clinical Trials Unit at Glasgow Royal Infirmary, analysed data from the West of Scotland Coronary... view more... (2001-01-22)
Statin treatment within first 24 hours after heart attack cut mortality by half
In the largest clinical study of its kind, UCLA researchers found that early treatment with a statin drug within 24 hours of having a heart attack reduced in-hospital mortality rates by over 50 percent. view more (2005-08-30)
Breakthrough in national diseases: Common factor behind myocardial infarction, rheumatism and MS
A common gene variant has been identified as the risk factor behind a number of common diseases by research scientists at Karolinska Institutet and the Centre for Molecular Medicine (CMM), Stockholm, Sweden. Up to a quarter of the population could be affected. view more (2005-04-08)
The mechanism of the life-threatening drug-interaction of Bayer's cholesterol-lowering agent Lipobay/Baycol clarified
Researchers from Finland have found that the cholesterol-lowering agent gemfibrozil (marketed as Lopid and generics) greatly increases the concentrations of cerivastatin (Lipobay or Baycol) in blood. This finding explains the observed muscle toxicity of the gemfibrozil-cerivastatin combination. This potentially fatal adverse effect of cerivastatin... view more... (2002-12-16)
|
|
| Page
3 of
8 |
144 Results |
|
|
|
Sort By:
Page Views | Date |
|
